Luhadia, Ashok – Trademark Portfolio

Entity Type: 01

Luhadia, Ashok holds 32 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 17 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include USPL, CHEWLET, BOSWIHERB, GARCIHERB, and GYMNAHERB. The owner is based in Monmouth Junction, NJ.

11 New Turkey Island Road

Monmouth Junction, NJ 08852

32 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (32 results)

Trademark Classifications

Luhadia, Ashok's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (17 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (15 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Luhadia, Ashok have?

Luhadia, Ashok has 32 U.S. trademarks filed with the USPTO. Of these, 5 registered, 6 abandoned, 21 cancelled.

What trademark classes does Luhadia, Ashok file in?

Luhadia, Ashok files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Luhadia, Ashok's most well-known trademarks?

Luhadia, Ashok's registered trademark portfolio includes well-known marks such as USPL, CHEWLET, BOSWIHERB, GARCIHERB, and GYMNAHERB. These are among 5 currently registered trademarks in the portfolio.

What is Luhadia, Ashok's trademark registration success rate?

Luhadia, Ashok has a 16% trademark registration rate, with 5 out of 32 resolved applications resulting in successful registration. Currently, 0 applications are pending review.